XML 42 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2012
Average Risk-free interest rate 0.52% 2.73%  
Average volatility 417.00% 242.00%  
Dividend Yield 0.00% 0.00%  
Outstanding options exercisable 2,452,000 152,000  
Shares of Series B Preferred Stock convertible 16,676,942 16,676,942  
Stock based compensation expense, options $ 122,000  
Compensation cost for non-employee consultants 25,000 $ 21,000  
Amortization 8,572 8,571  
Future amortization, yearly 6,071    
Depreciation 1,093 1,094  
Royalties $ 156 1,027  
Gain on warrants issued   26,660  
Gain on exchange   26,660  
FluoroPharma [Member]      
Gain on warrants issued   $ 20,660 $ 115,752
Reassignment of warrants   109,917  
Warrant price   $ 1.00  
Gain on exchange   $ 20,660 $ 115,752
Minimum [Member]      
Property and equipment useful life 3 years    
Maximum [Member]      
Property and equipment useful life 7 years    
Patents [Member]      
Useful lives 17 years    
Licensing Agreements [Member]      
Useful lives 10 years    
Computer Software, Intangible Asset [Member]      
Useful lives 3 years    
Acquired Intangibles [Member]      
Useful lives 15 years